JP2024542235A5 - - Google Patents
Info
- Publication number
- JP2024542235A5 JP2024542235A5 JP2024529873A JP2024529873A JP2024542235A5 JP 2024542235 A5 JP2024542235 A5 JP 2024542235A5 JP 2024529873 A JP2024529873 A JP 2024529873A JP 2024529873 A JP2024529873 A JP 2024529873A JP 2024542235 A5 JP2024542235 A5 JP 2024542235A5
- Authority
- JP
- Japan
- Prior art keywords
- cys
- seq
- amino acid
- scfv
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163281954P | 2021-11-22 | 2021-11-22 | |
| US63/281,954 | 2021-11-22 | ||
| US202263322158P | 2022-03-21 | 2022-03-21 | |
| US63/322,158 | 2022-03-21 | ||
| US202263393750P | 2022-07-29 | 2022-07-29 | |
| US63/393,750 | 2022-07-29 | ||
| PCT/IB2022/061241 WO2023089587A1 (en) | 2021-11-22 | 2022-11-21 | Compositions comprising enhanced multispecific binding agents for an immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542235A JP2024542235A (ja) | 2024-11-13 |
| JP2024542235A5 true JP2024542235A5 (cg-RX-API-DMAC7.html) | 2025-12-01 |
Family
ID=84370675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529873A Pending JP2024542235A (ja) | 2021-11-22 | 2022-11-21 | 免疫応答のための増強された多重特異性結合剤を含む組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250320304A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4436669A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024542235A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240111783A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022392829A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3239224A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312968A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024006205A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023089587A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL326398A (en) * | 2023-08-07 | 2026-04-01 | Janssen Biotech Inc | Gucy2c antibodies and uses thereof |
| US20250361317A1 (en) | 2024-05-24 | 2025-11-27 | Janssen Biotech, Inc. | Bispecific antibody targeting emr2 (cd312) and the t-cell receptor trbv19 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6255458B1 (en) | 1990-08-29 | 2001-07-03 | Genpharm International | High affinity human antibodies and human antibodies against digoxin |
| US5932448A (en) | 1991-11-29 | 1999-08-03 | Protein Design Labs., Inc. | Bispecific antibody heterodimers |
| US5635483A (en) | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| US5780588A (en) | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| DE60131456T2 (de) | 2000-11-30 | 2008-07-10 | Medarex, Inc., Milpitas | Transchromosomale transgen-nagetiere zur herstellung von humanen antikörpern |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| US6833441B2 (en) | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
| KR101374454B1 (ko) | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| DK1999154T3 (da) | 2006-03-24 | 2012-12-03 | Merck Patent Gmbh | Fremstillede heterodimere proteindomæner |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| US20080226635A1 (en) | 2006-12-22 | 2008-09-18 | Hans Koll | Antibodies against insulin-like growth factor I receptor and uses thereof |
| AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
| EP2282769A4 (en) | 2008-04-29 | 2012-04-25 | Abbott Lab | DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES |
| US9067986B2 (en) | 2009-04-27 | 2015-06-30 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| WO2011143545A1 (en) | 2010-05-14 | 2011-11-17 | Rinat Neuroscience Corporation | Heterodimeric proteins and methods for producing and purifying them |
| EP2420253A1 (en) | 2010-08-20 | 2012-02-22 | Leadartis, S.L. | Engineering multifunctional and multivalent molecules with collagen XV trimerization domain |
| CN103429620B (zh) | 2010-11-05 | 2018-03-06 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| IN2014CN03887A (cg-RX-API-DMAC7.html) | 2011-10-27 | 2015-10-16 | Genmab As | |
| US9574010B2 (en) | 2011-11-04 | 2017-02-21 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the Fc domain |
| US9527927B2 (en) | 2011-12-20 | 2016-12-27 | Medimmune, Llc | Modified polypeptides for bispecific antibody scaffolds |
| WO2013157953A1 (en) | 2012-04-20 | 2013-10-24 | Merus B.V. | Methods and means for the production of ig-like molecules |
| PT2970980T (pt) | 2013-03-15 | 2018-11-19 | Janssen Biotech Inc | Métodos de produção para controlor o teor de lisina c-terminal, galactose e ácido siálico em proteínas recombinantes |
| JP6696982B2 (ja) * | 2014-11-26 | 2020-05-20 | ゼンコー・インコーポレイテッドXencor、 Inc. | Cd3および腫瘍抗原に結合するヘテロ二量体抗体 |
| CN109843926B (zh) | 2016-09-30 | 2023-01-20 | 豪夫迈·罗氏有限公司 | 针对cd3的双特异性抗体 |
| TW202120537A (zh) * | 2019-08-15 | 2021-06-01 | 美商健生生物科技公司 | 用於經改善的單鏈可變片段之材料及方法 |
-
2022
- 2022-11-21 EP EP22817370.4A patent/EP4436669A1/en active Pending
- 2022-11-21 CA CA3239224A patent/CA3239224A1/en active Pending
- 2022-11-21 WO PCT/IB2022/061241 patent/WO2023089587A1/en not_active Ceased
- 2022-11-21 KR KR1020247020460A patent/KR20240111783A/ko active Pending
- 2022-11-21 JP JP2024529873A patent/JP2024542235A/ja active Pending
- 2022-11-21 IL IL312968A patent/IL312968A/en unknown
- 2022-11-21 MX MX2024006205A patent/MX2024006205A/es unknown
- 2022-11-21 US US18/711,312 patent/US20250320304A1/en active Pending
- 2022-11-21 AU AU2022392829A patent/AU2022392829A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210189011A1 (en) | Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation | |
| JP7600327B2 (ja) | Pd-1とvegfを標的とした四価二重特異性抗体、その製造方法および用途 | |
| JP2022079549A5 (cg-RX-API-DMAC7.html) | ||
| HRP20241775T1 (hr) | Bispecifična protutijela koja se specifično vežu na pd1 i lag3 | |
| JP2019533441A5 (cg-RX-API-DMAC7.html) | ||
| JP2018502050A5 (cg-RX-API-DMAC7.html) | ||
| FI3561057T3 (fi) | Anti-cd3-vasta-aine ja vasta-ainetta sisältäviä molekyylejä | |
| CN119032104A (zh) | 抗血清白蛋白纳米抗体及其衍生物 | |
| JP2023139025A (ja) | 二重特異性抗原結合コンストラクト | |
| JP7826320B2 (ja) | 二重または多重特異性抗体{Bi or Multi-Specific Antibody} | |
| RU2024116415A (ru) | Композиции, содержащие улучшенные мультиспецифические связывающие агенты для иммунного ответа | |
| JP2022545368A5 (cg-RX-API-DMAC7.html) | ||
| HK40050601A (en) | Dual variable region antibody-like binding proteins having cross-over binding region orientation | |
| RU2022103028A (ru) | Антитела против рецептора программируемой смерти pd-1 человека | |
| RU2021118725A (ru) | Биспецифические антитела, связывающиеся с tfr | |
| HK1247929A1 (en) | Dual variable region antibody-like binding proteins having cross-over binding region orientation | |
| HK1247929B (en) | Dual variable region antibody-like binding proteins having cross-over binding region orientation | |
| RU2022133024A (ru) | Анти-cd3 антитело и молекула, содержащая это антитело | |
| HK1194744B (en) | Dual variable region antibody-like binding proteins having cross-over binding region orientation |